ProCE Banner Activity

Emerging Biological Therapies on the Horizon for β-Thalassemia

Slideset Download

Download this slideset for an expert-curated overview of emerging biological therapies for &beta -thalassemia including review of the latest clinical data leading to the recent approval of the erythroid maturation agent luspatercept for transfusion-dependent disease.

Released: December 06, 2019

Expiration: December 04, 2020

No longer available for credit.

Share

Faculty

Maria Domenica Cappellini

Maria Domenica Cappellini, MD

Professor of Internal Medicine
Chief, Internal Medicine Unit
Internal Medicine Department
University of Milan-Fondazione IRCCS Ca Granda Policlinico Hospital
Milan, Italy

Provided by

ProCE Banner

Supporters

Celgene